BOSTON SCIENTIFIC CORP — Director's Dealing 2013

Mar 4, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2013-02-28

Reporting Person: Carruthers Wendy (SVP, Human Resources)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-28	Common Stock	M	2793.0000	$0.0000	Acquired	45070.0000	Direct
2013-02-28	Common Stock	F	911.0000	$7.3900	Disposed	44159.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-28	Deferred Stock Units	$	M	2793.0000	Disposed	2016-02-28	Common Stock (2793.0000)	Direct
2013-02-28	Deferred Stock Units	$	A	18606.0000	Acquired	2018-02-28	Common Stock (18606.0000)	Direct
2013-02-28	Stock Option (Right to Buy)	$7.3900	A	48439.0000	Acquired	2023-02-28	Common Stock (48439.0000)	Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F3: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.

F4: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.

F5: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.